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Abstract
DNA topoisomerase II (topo II) catalyzes a strand passage reaction in that one duplex is passed through a transient brake or
gate in another. Completion of late stages of neuronal development depends on the presence of active b isoform (topo IIb).
The enzyme appears to aid the transcriptional induction of a limited number of genes essential for neuronal maturation.
However, this selectivity and underlying molecular mechanism remains unknown. Here we show a strong correlation
between the genomic location of topo IIb action sites and the genes it regulates. These genes, termed group A1, are
functionally biased towards membrane proteins with ion channel, transporter, or receptor activities. Significant proportions
of them encode long transcripts and are juxtaposed to a long AT-rich intergenic region (termed LAIR). We mapped genomic
sites directly targeted by topo IIb using a functional immunoprecipitation strategy. These sites can be classified into two
distinct classes with discrete local GC contents. One of the classes, termed c2, appears to involve a strand passage event
between distant segments of genomic DNA. The c2 sites are concentrated both in A1 gene boundaries and the adjacent
LAIR, suggesting a direct link between the action sites and the transcriptional activation. A higher-order chromatin structure
associated with AT richness and gene poorness is likely to serve as a silencer of gene expression, which is abrogated by topo
IIb releasing nearby genes from repression. Positioning of these genes and their control machinery may have developed
recently in vertebrate evolution to support higher functions of central nervous system.
Citation: Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase IIb Activates a Subset of Neuronal Genes that Are Repressed in AT-Rich
Genomic Environment. PLoS ONE 3(12): e4103. doi:10.1371/journal.pone.0004103
Editor: Laszlo Tora, Institute of Genetics and Molecular and Cellular Biology, France
Received September 8, 2008; Accepted November 26, 2008; Published December 31, 2008
Copyright:  2008 Sano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by Grant-in-Aid for Scientific Research funding to K. T. from the MEXT, Japan. The funding agency had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tsukken@cc.okayama-u.ac.jp
. These authors contributed equally to this work.
Introduction
In the cell division cycle, gated passage for chromosomal DNA
strands is an essential requirement for disentanglement of the
DNA link between post-mitotic sister chromatids prior to
segregation. The process is catalyzed by the a isoform of topo II
that evolved from a single eukaryotic gene through a gene
duplication event, which occurred around the time of vertebrate
diversification. Topo IIa and its counterpart b (topo IIb) exhibit
similar enzymatic properties on naked DNA in vitro [1]. However,
as the timing and tissue specificity of expression differs substan-
tially between these isoforms, it is a reasonable assumption that
they share separate roles in cellular physiology. Two research
groups, including our own, reported the evidence supporting this
notion by showing that topo IIb is required in the late stage of
neural differentiation probably through transcriptional induction
of neuronal genes [2–4]. More recently, other studies demonstrat-
ed the regulatory role of topo IIb in the transcriptional activation
of some inducible genes [5,6]. Use of expression arrays indicated
that transcript levels of only a subset of genes are susceptible to
depletion of topo IIb in differentiating neural tissues [3,7]. Why
the enzyme controls only a fraction of genes remained unclear. To
answer this question and to elucidate the mechanism of gene
regulation by topo IIb, we hypothesized that relative topograph-
ical relationship between topoisomerase action sites and the
location of genes controlled by the enzyme should provide an
important clue.
A group of topo II inhibitors such as etoposide, often called
topoisomerase poisons, have been used to map the topo II action
sites on DNA. The drug binds specifically to the enzyme and
stabilizes the topo II-DNA covalent complex (cleavable complex)
by preventing the ligation of the transiently cleaved DNA strands
[8]. Upon addition of strong detergents, the complex is disrupted
to liberate DNA fragments with denatured topo II protein
covalently attached to their 59-termini [9]. The drug-induced
cleavage sites are then mapped by measuring the distance from
end-labeled restriction fragments by Southern blotting. Consensus
nucleotide sequences surrounding the cleavage sites have been
deduced from in vitro experiments with naked DNA and purified
enzymes [10–12]. As most topo II poisons are permeable into
living cells, topo II sites in vivo was also mapped with various cell
systems [13]. It was suggested that the in vivo cleavage sites are
highly restricted by the local chromatin structure, being located
mostly in the linker segment between phased nucleosomes [14–
16]. In addition, topo II sites detected in vivo do not always
coincide with strong naked DNA sites but often correspond to only
minor in vitro sites. It is clear then that the topo II cleavage
consensus in vitro is inadequate to predict its in vivo sites. It has been
generally accepted that topo II cleavage sites are within an AT-
rich region often in the vicinity of the matrix attachment region
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mapping of in vivo topo II action sites has not been attempted.
The mapping technique used in the present study also utilizes
etoposide to enrich the reaction intermediate, but the enzyme-
DNA complex was recovered by lysing the cells in milder
conditions without strong denaturants [18]. After fragmentation
of chromosomal DNA, the topo IIb -DNA covalent complex was
concentrated by immunoprecipitation with specific antibody.
Resulting DNA fragments were amplified by ligation-mediated
PCR and hybridized to tiling arrays to determine their genomic
positions. This protocol is similar to chromatin immunoprecipi-
tation (ChIP) except that the cross-linking is based on the
formation of topo II-specific reaction intermediate. Thus, the
procedure can be regarded as ‘‘functional ChIP’’. The use of mild
conditions for arresting the intermediate brought about two
advantages. First, as topo IIb was linked to DNA mostly through
single strand breakage, the cleavage site resided within the
fragment and both ends were available for ligation of amplification
primers. Second, the other DNA strand, which is transferred
through the cleaved strand, remains associated with the enzyme in
the immunoprecipitate. This DNA fragment can be recovered in a
separate fraction by a stringent washing when it is not contiguous
to the cleaved strand. This topo II site mapping strategy,
combined with expression array analysis of topo IIb-regulated
genes, enabled us to identify AT-rich genomic sites that appear to
be essential for linking topo IIb action to its target genes.
Because of complicated terminology used in the study, we
provide an explanatory document in Supporting Information to
avoid possible confusions (Text S1).
Results
In the primary culture of newborn cerebellar tissue that we used
in this study, only precursor granule neurons can survive after the
final division in vitro [19]. It is a useful experimental system to study
the transcriptional induction of neuronal genes during the post-
mitotic differentiation that proceeds spontaneously and almost
synchronously. In addition, topo IIb is the only target of topo II-
specific inhibitors since these cells do not express topo IIa [3].
Expression of topo IIb can be inhibited specifically throughout the
culture period if ICRF-193, a topo II-specific inhibitor, was added
daily.
Unique identity of topo IIb-induced genes
We first categorized the genes expressed in differentiating
cerebellar neurons by analyzing the expression array data on the
basis of combination of two factors: induction rate during
differentiation and susceptibility to ICRF-193. The inhibitor not
only inhibits the activity but also depletes the enzyme by selective
degradation [20], practically knocking it down at the protein level
(Figure 1A). The array data were plotted as a scattered graph of
fold-induction versus fold-inhibition and the corresponding genes
were classified into 9 groups (Figure 1B). Groups A1, A2, B2, and
unexpressed genes (group D) comprised about 90% of analyzed
genes (Figure 1C and Figure S5A). The group A1 that makes up
only 2.6% is the primary target of the present study since these
genes are up-regulated depending on topo IIb. A2 genes are also
up-regulated but are not susceptible to the topo II inhibitor. B2
genes, the largest group, are expressed constitutively and
independently of topo IIb. The array results were confirmed by
reverse transcription-quantitative PCR (RT-qPCR) experiments
for representative genes from each group (Data S1; Figure S1).
Knocking down topo IIb by RNA interference, instead of ICRF-
193, was not suitable for our experimental strategy since some A1
genes got already induced before topo IIb level was significantly
reduced. However, auxiliary use of the inhibitor at the initial step
of the culture demonstrated that topo IIb siRNA is also effective to
inhibit the A1 gene induction (Figure S2).
To see whether these expression groups reflect some functional
characteristics, the gene ontology (GO) database was used to find
over- or under-represented terms in each group (Figure 1D). GO
terms related to neuronal function (channel, transporter, receptor
activities) were clearly over-represented in A1 genes whereas the
same terms were not enriched in A2 and were under-represented
in B2 genes. Characteristic GO terms in A2 genes were
extracellular matrix and anion transport (Table S5). Thus, A1
and A2 are functionally distinct gene groups although their
expression levels both increase during differentiation. As expected,
the GO analysis showed that B2 genes are mostly housekeeping
genes. Interestingly, unexpressed genes (group D) shared consid-
erable GO terms with A1 genes, suggesting that this gene group
might behave like A1 in other neural tissues or in other
developmental stages.
Genomic environment of A1 genes
We next explored how A1 genes are physically different from
the other gene groups. When locating A1 genes on genome
browser displays, we noticed that they frequently reside close to
large gene-poor regions that are mostly AT-rich. For this type of
analysis, we first constructed a rat genome compilation (exRefSeq)
by combining the data from rat, mouse, and human RefSeq genes
(Figure S3). The rat genome was then divided into genic and
intergenic regions and they were further classified into four classes
each by length and GC content (Figure S4). In the present report,
the word ‘‘genic’’ stands for transcribed regions of protein-coding
genes. The intergenic region named LAIR (long AT-rich
intergenic region) has a large genomic coverage (50% of intergenic
and 35% of total genome). About 11% of rat genes were
juxtaposed to LAIR (designated LAIR proximal). GC contents of
LAIR-proximal genes were clearly biased towards AT-rich side in
base composition as compared with genes that are not juxtaposed
to LAIR (LAIR distal) (Figure 2A). When compared with other
classified gene groups, a higher proportion of A1 genes (24%) were
LAIR proximal with statistical significance (Figure S5B). Further-
more, the LAIR-proximal A1 gene contained a distinct population
of large genes (.74 kb) as shown in Figure 2B. No such
subpopulation was present in other gene groups as well as in
LAIR-distal genes (not shown).
Therefore, typical A1 genes can be characterized by three
properties: LAIR-proximal, long, and AT-rich. The category of
genes with all these characters will be referred to as ‘‘LA genes’’
hereafter. We adopt the average gene length (51 kb) and overall
GC content (0.44) to define the thresholds (Figure S4). A two
dimensional representation of these variables showed that about
80% of LAIR-proximal but only 10% of LAIR-distal A1 genes are
long and AT-rich (Figure 2C). The proportion of LA gene in total
A1 genes was significantly higher than that of other gene groups
(Figure 2D). The strong link between A1 and LA genes was further
demonstrated by the gene ontology analysis (Figure 2E). A higher
proportion of A1 genes (68%) shared statistically significant GO
terms with LA gene as compared to other gene groups (see also
Figure S6).
Based on these results, it should be possible to predict LAIR-
proximal A1 genes without knowing their actual response to topo
II inhibitors. To test this, from the genes without any assigned
array probes (group N), we selected five LA genes that are up-
regulated during the cerebellar differentiation and sharing similar
GO terms with A1 genes. Expression profiles analyzed by RT-
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A1 genes (Figure S7), corroborating the hypothesis that topo IIb
requirement for transcriptional induction of a gene is closely
related to its genomic environment.
Mapping of topo IIb action sites
As a next step, we intended to locate direct action sites of topo
IIb on DNA, not just binding sites. This can be done by using
etoposide, a topoisomerase poison, which stabilizes the reaction
intermediate to cross-link the enzyme to DNA at the site of action.
The enzyme-DNA complex was recovered by immunoprecipita-
tion with specific antibody. We name this technique eTIP for
etoposide-mediated topoisomerase immunoprecipitation (shown
schematically in Figure 3A). Treatment of the topo II-DNA
complex with strong denaturants like SDS generates a double
strand DNA break with denatured enzyme covalently attached to
Figure 1. Topo IIb is required for the induction of selective genes in differentiating cerebellar granule cells. (A) The protocol outline for
the analysis of gene expression in rat granule cells in culture. When a specific inhibitor ICRF-193 is added, topo IIb is degraded rapidly as shown below
by immunoblotting. RNA samples were prepared at the time points indicated and subjected to microarray analysis. D1, day 1; D5, day 5; D5+, day 5 in
the presence of inhibitor. (B) Grouping of array signals by a scatter graph of induction versus inhibition. Logarithm of signal intensity ratios, (D5)/(D1)
vs. (D5+)/(D5), were plotted. Data points separated by 2-fold and 0.5-fold lines are grouped as labeled. (C) A pie graph representation for the rate of
genes in each expression group. ‘‘D’’ is unexpressed genes. Other groups of minor population are put together into ‘‘O’’. (D) Functional
characterization of the expression groups by gene ontology (GO) analysis. The result shown here is sorted by P-values for A1 group in the decreasing
order of statistical significance. Words frequently appear in the term description are shown in red. Overrepresented (P,10
24) and underrepresented
(2P,10
24) terms are highlighted.
doi:10.1371/journal.pone.0004103.g001
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conditions with a combination of detergent (Sarkosyl) and high
salt (CsCl) to preserve the topo II dimer structure attached to a
segment of DNA (G-segment) through a single strand break. An
important consequence here was that the other segment (T-
segment) is also trapped noncovalently and released later by high-
salt treatment when it is not contiguous to the cleaved strand
(Figure 3A, Step 5).
We confirmed the legitimacy of eTIP procedure by using a
model reaction with circular DNA substrate and nuclear extract as
enzyme source (Figure 3B). It should be noted that in this system
G- and T-segments are contiguous in one strand and no DNA will
be released in P2 fraction but complete reversion of the
intermediate after immunoprecipitation step would generate
closed circles in P2. The nuclear extract contains topoisomerase
I activity and supercoiled substrate was completely relaxed in the
absence of ATP, whereas nuclease activity in the extract was
negligible (Figure 3C, lane 2). When the reaction was stopped by
Sarkosyl-CsCl under the conditions used for eTIP, open circular
form II DNA was generated depending on etoposide (Figure 3C,
lane 4) and immunoprecipitated by topo IIb antibody (Figure 3D).
Thus, form II DNA in P1 can be accounted for by the topo IIb
cleavable complex arrested at single strand breakage (CCssb). No
form II or form Ir relaxed DNA was detected in P2 fraction
indicating that the enzyme-DNA complex is not dissociated from
the beads and reversal of the cleavage does not take place in the
stringent washing conditions (Figure 3D). As expected, form III
DNA instead of form II DNA was detected in P1 fraction when
SDS was used in place of Sarkosyl-CsCl to stop the reaction
(Figure 3D).
To evaluate the specificity of eTIP, DNA yields in the eTIP
fractions were compared in four conditions (Figure 3E). Cell
lysates from granule cells with or without etoposide treatment were
immunoprecipitated with either control mouse IgG or anti-topo
Figure 2. A1 genes occupy a unique position in the genome. (A) Genes juxtaposed to LAIR (LAIR proximal) are more AT-rich than the rest of
the genes (LAIR distal). The difference in overall GC contents between the two groups is highly significant (P,10
215). (B) A considerable proportion
of LAIR-proximal A1 genes have a long transcribed region. Percentiles of the LAIR-proximal genes are plotted against the logarithm of distance from
the margin of LAIR. (C) Contour maps of frequency distribution for LAIR-proximal (A1p) and LAIR-distal (A1d) A1 genes as a function of logarithmic
gene length and GC content. Relative frequency levels are reflected in thermal display. The boxed area represents ‘‘long and AT-rich’’. (D) Relative
frequency of LA genes in various expression groups. The occurrence rate of LA gene in all gene groups (broken line) was used as a reference for chi-
squire test. (E) Percentages of GO terms shared between LA gene and various expression groups. Only significant GO terms (P,10
24) overlapping
with those of LA genes were counted.
doi:10.1371/journal.pone.0004103.g002
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fractions were dependent on etoposide treatment and antibody
specificity, indicating that DNA in both fractions derived from the
arrested intermediate of topo IIb. To see whether topo IIb is
present in P2 fraction, nuclease-treated fractions were subjected to
Western blotting (Figure 3F). Absence of topo IIb protein in P2
fraction is consistent with the notion that substantial amount of
DNA in P2 most likely originates from the T-segment trapped in
the topo IIb CCssb, and not from salt-labile antibody-enzyme
interactions.
For genome-wide mapping of topo IIb action sites (termed
toposites), the eTIP DNA fractions were prepared at the second
day of granule cell differentiation. We chose this timing because
mRNA expression is maximally induced by day 3 in many A1
genes (see Figure S1), indicating that the involvement of topo IIb
in gene induction starts before day 3. In addition, our previous
study showed that topo IIb is required only in the early period of
culture [3]. DNA fragments purified from P1 and P2 fractions
were hybridized to tiling arrays. In designing the array, we selected
7 genomic regions (about 79 Mb in total), each containing at least
one A1 gene. A correlational analysis with statistically significant
P1 signals from the array data suggested that P1 DNA is composed
of two components (Figure 4A). Multi-factor clustering of P1
signals against P2 signals and local GC content clearly separated
the toposites into 2 classes (Figure 4B). The scatter graph indicates
that one of the classes, labeled c1, was detected only in P1 fraction
whereas c2 was present in both P1 and P2 fractions. The
frequency distribution also showed that the two factors used for the
clustering are well discriminated in the resulting classes: the c1 site
depleted from P2 is GC-rich and the c2 site enriched in both P1
and P2 is AT-rich (Figure 4C). These results were consistent with
the preliminary observation obtained by shotgun cloning of eTIP
DNA fractions (Figure S8).
To avoid possible confusions, the relationship among the terms
used in the study is represented schematically in Figure 4D.
Unique positions on the genome are labeled A or B, which can be
Figure 3. The two segments of DNA interacting with topo IIb in action can be separated by e-TIP. (A) Schematic representation of the
eTIP/tiling array procedure. Type II topoisomerase cleaves a DNA duplex (G-segment, blue) to make a gate for another duplex (T-segment, red) to be
transferred through. In the eTIP procedure, both DNA segments are separated together from other DNA fragments in the immunoprecipitation step
(Step 4) and separated later into P1 and P2 DNA fractions that are enriched in G-segment and T-segment, respectively (Step 5). Chromatin proteins
(depicted as spheres) are largely dissociated from DNA in Step 2. (B) Schematic representation of an eTIP model reaction in vitro. Plasmid pUC18 was
incubated with rat brain nuclear extract containing topo IIb, in the presence of etoposide. The reaction was stopped by SDS or Sarkosyl-CsCl and the
DNA cross-linked to the enzyme was fractionated by immunoprecipitation under eTIP conditions. NE, nuclear extract; CCdsb, cleavable complex with
double strand break; CCssb, cleavable complex with single strand break; IP, immunoprecipitation; P1/P2, IP fractions; SDS/PK, Proteinase K treatment
in presence of SDS; I, supercoiled DNA; II, nicked circles; Ir, relaxed circles; III, linear DNA. (C) Topo II reactions with or without components indicated
were terminated by Sarkosyl-CsCl or SDS. Samples were treated with SDS/PK and separated in 1% agarose gel electrophoresis with 0.5 mg/ml
ethidium bromide. (D) After the topo II reaction with etoposide (lane 4 and 6 in Figure 3C), products were fractionated under eTIP conditions and
purified DNA was analyzed by agarose gel electrophoresis. M, DNA markers; In, input for immunoprecipitation, IP, immunoprecipitate; P1/P2, IP
fractions. (E) The eTIP DNA fractions P1 and P2 were obtained from granule neurons at day 2 under the conditions indicated. The DNA yield shown
here is from one plate of culture (,2.5610
7 cells). (F) Detection of topo IIb in eTIP fractions. Cultured granule neurons treated with etoposide were
subjected to eTIP analysis as described. IP samples, with or without DNase I digestion, were directly applied to 6.5% SDS-PAGE and analyzed by
immunoblotting with anti-topo IIb IgG. H, heavy chain of IgG.
doi:10.1371/journal.pone.0004103.g003
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toposite shown on the left column does not generate free DNA in
P2 fraction. This situation corresponds to the model experiment
with plasmid DNA (Figure 3B). If the distance between A and B
are larger than ,5 kb, these sites are likely to reside on separate
fragments since the average fragment size is less than 5 kb. In this
case both genomic regions (A and B) are detected in both DNA
fractions (P1 and P2) and the action site is classified as c2.
Positions of c1 and c2 toposites in all the analyzed chromosomal
regions are illustrated in Figure S9. As expected, the pattern of
global toposite distribution appeared to reflect the local GC
content. Although less frequently, toposites were detected also in
unexpressed genes (group D) and in genes whose expression is
independent of topo IIb. It is worth noting that Ndst4, an A1 gene
predicted from the positional information (Figure S7), is located in
the tiled region on chromosome 2. Ndst4 and the adjacent LAIR
are both enriched with c2 toposites.
Topographical link between toposites and A1 genes
It is reasonable to assume a certain topographical relationship
between genomic locations of toposites and the regulated genes,
namely A1 genes. As a whole, less than one toposite was present in
every 10 kb for both c1 and c2 sites (Figure 5A, B). These sites,
however, were concentrated or depleted in particular genomic
regions depending on their regional GC contents. As defined in
Figure S4, genomic regions were classified into 8 classes. c1 sites
are clearly enriched in GC-rich genic regions (Figure 5A). The c1
site enrichment in short GC-rich intergenic regions may reflect
promoters within gene-dense genomic areas (Figure S9). For both
genic and intergenic regions, c2 sites are largely depleted from
Figure 4. Mapping of topo IIb action sites reveals two distinctive genomic targets. (A) Analysis of eTIP DNA fractions on tiling arrays
showed a binary nature of the composition of P1 DNA as plotted against P2/input or local GC content around toposites (6250 bp from the probe
centre). (B) A plot of significant P1 signals scattered along the P1 and P2 axes after clustering with P2/input and local GC content (Ward’s method).
Two classes of toposites (c1, c2) are distinguished and their numbers (n) are indicated. (C) Frequency distribution of classified toposites against P2/
input or local GC content, demonstrating the successful classification of toposites by the clustering approach. (D) Diagram of the relationship among
G/T-segments, P1/P2 IP fractions, and c1/c2 toposites. Unique genomic sites involved in the reaction with topo IIb are labeled A and B.
doi:10.1371/journal.pone.0004103.g004
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(Figure 5B). The tiled region contained 318 genes, of which 140
(44%) harbored more than one toposite per gene and 32 (10%)
were LA genes. A large proportion of LA gene (81%) contained
toposites as compared to non-LA genes (40%). When classified
toposite densities in the genic region were compared, c1 sites were
significantly enriched in non-LA genes, whereas c2 sites were
concentrated in LA genes (Figure 5C).
To see whether toposites are clustered in a particular region
with respect to genes, we finally analyzed the site distribution at
the boundary of transcription units that were aligned either at the
transcription start site (TSS) or at the termination site (TTS)
(Figure 5D). A discrete peak of c1 site was detected around TSS in
A1 and D groups, while A2 gene exhibited multiple c1 peaks
around TSS and inside the gene. Distribution of c1 sites in the 39
region of A1 and A2 genes was more irregular but appeared to be
confined within the transcription unit. In contrast to c1 sites, c2
sites were basically restricted to A1 genes. When A1 genes were
sorted into two groups, LAIR proximal (A1p) and LAIR distal
(A1d), it is now clear that c2 sites are located exclusively around
A1p genes (Figure 5E). All the LAIR-proximal A1 genes found in
the tiled region were LA genes whose promoters were present
inside the adjacent LAIR (Table 1). Thus, c2 sites are likely to be
essential for the regulated expression of LA genes. Meanwhile,
LAIR-distal A1 genes appear to be regulated by c1 sites.
Discussion
Type II DNA topoisomerases catalyze the strand passage events
between the two segments of DNA, termed G- and T-segments
[21]. The G-segment contains the transient gap generated by the
enzyme for the passage of T-segment. Under the conditions used
in the eTIP procedure, the enzyme-DNA intermediate is
converted mainly to a form with a single-strand breakage at the
site of action, suggesting that the cleavage sites on G-segments are
concentrated in the P1 DNA fraction (Figure 3A). The DNA yield
experiments demonstrate the specificity of recovered DNA
fragments in terms of etoposide treatment and binding to topo
IIb. The absence of DNA in the P2 fraction without etoposide
treatment is a strong evidence for the assumption that P2 DNA is
directly associated with the reaction intermediate of topo IIb, not
just with the enzyme. It also indicates that little nonspecific DNA is
contaminating the P2 DNA fraction, implying that the stringency
of washing conditions in Step 4 is sufficient. Thus, the DNA in P2
fraction is closely involved in the topoisomerase reaction and most
likely representing the T-segments that are trapped between the
Figure 5. Patterns of toposite distribution corroborate the involvement of topo IIb in the transcriptional regulation of A1 genes.
Regional frequency of toposites expressed by number of sites per 10 kb (site density). Subgenomic regions are classified into 8 classes by their length
and GC content (Figure S4). L, long; S, short. (A) Density distribution of c1 toposite. (B) Density distribution of c2 toposite. (C) Reciprocal distribution
of the two classes of toposites in LA gene and the rest of the genes (non-LA gene). The difference between these gene groups is highly significant
(*P,10
279). (D) Clustering of toposites around the border of transcription units. Toposite densities expressed as scan units are shown on the vertical
axis (full scale=2.0). The randomly generated toposite controls for each gene group are plotted together (overlaid) on the bottom. (E) LAIR-proximal
A1 genes are characterized by the presence of c2 toposites around the boundaries of transcription units. A1p, LAIR-proximal A1; A1d, LAIR-distal A1.
doi:10.1371/journal.pone.0004103.g005
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successful retention (Step 2) and release (Step 5) of T-segments in
the eTIP procedure may be accounted for by the difference in the
chaotropic potential of the cations used in these steps: Cs
+ and
Na
+, respectively.
The characteristic partitioning of DNA fragments into eTIP
fractions (P1 and P2) provided an important clue to understanding
the mechanism of topo IIb action in vivo. A working hypothesis
implied by the present study is summarized in Figure 6A. We
suppose that 1) the enzyme can recruit any part of the genome as
G- or T-segment. 2) The enzyme has little preference as to which
segment should be G or T. 3) If G- and T-segments are on
different DNA fragments, the eTIP procedure sorts these DNA
segments into P1 and P2 fractions, respectively. When G- and T-
segments are closely positioned on the genome, for instance less
than 5 kb, both segments will be recovered in P1 and the site is
classified as class 1 (c1). In this case, the most probable topological
change caused by the reaction is the relaxation of superhelical
turns that are built up locally [22]. This reaction may facilitate the
initiation or elongation steps of transcription. In contrast, when
these DNA segments are located distantly, they are inevitably
separated into P1 and P2 fractions interchangeably and the site is
classified as class 2 (c2). An essential prerequisite for this type of
reaction is the formation of a DNA crossing, which is preferentially
recognized by topo II [23]. Since the crossed DNA segments can
either be G- or T-segment by chance, they are fractionated into
both IP fractions, P1 and P2. These crossings should occur more
frequently at the base of chromatin loops that are maintained by
the interaction between MAR and the nuclear matrix. This is
consistent with the fact that MAR is usually found in AT-rich
region like c2 toposites. The strand passage at inter-loop c2 sites
causes catenation or decatenation between the loops that are
equivalent to topologically independent DNA circles. These
topological changes may induce the decondensation of local
chromatin structure [24], leading to the formation of active
initiation complex for productive transcription.
Transcriptional profiling of topo IIb knockout mouse embryos
showed that the enzyme regulates only a small fraction of genes (1–
4%) in the late embryonic brain cells [7]. When the down-
regulated genes in the knockout mice were compared to our
results, a significant proportion of them were A1 genes or LA
genes, being consistent with the idea that similar subsets of genes
with similar genomic locations are controlled by topo IIb in the
late stages of neuronal development (Figure S10). Involvement of
topo IIb has also been reported in nuclear receptor-mediated
regulation of inducible genes [5,6]. In these cases, however, the
enzyme mostly targets the promoter region of non-LA genes. We
further noticed a striking parallelism between our findings and the
widespread monoallelic expression of human autosomal genes
[25]. Large fraction of monoallelically expressed genes encodes cell
surface and membrane proteins. All the GO terms over-
represented in these genes with high statistical confidence (Table
S3 in the report) coincided with those terms for LA gene (Table
S5). Re-analysis of their data indeed showed a high incidence of
LA genes in the monoallelic expression group (Figure S11).
Similarly, a large proportion of autism-related genes identified in
Table 1. List of A1 genes located in the region analyzed by tiling array.
Gene name Chr Length GC Long AT-rich LA gene 59-LAIR
LAIRp PKIA 2 75,379 0.377 1 1 1 1
NDST3 2 168,066 0.416 1 1 1 1
NDST4 2 337,446 0.381 1 1 1 1
CAMK2D 2 269,505 0.414 1 1 1 1
KCND2 4 507,449 0.382 1 1 1 1
CNTN4 4 856,312 0.392 1 1 1 1
PDE4B 5 468,195 0.407 1 1 1 1
GABRB2 10 224,006 0.383 1 1 1 1
SGCD 10 404,807 0.407 1 1 1 1
CDH11 19 156,643 0.389 1 1 1 0
LAIRd ANK2 2 321,155 0.424 1 0 0 0
TSPAN33 4 23,520 0.478 0 0 0 0
D330017J20RIK 4 52,406 0.449 1 0 0 0
ITPR1 4 324,832 0.443 1 0 0 0
CPNE9 4 23,676 0.474 0 0 0 0
RAVER2 5 79,562 0.448 0 0 0 0
SLC35D1 5 46,149 0.440 0 0 0 0
DAB1 5 150,599 0.443 1 0 0 0
ADAM19 10 92,490 0.469 0 0 0 0
RRAD 19 3,241 0.536 0 0 0 0
PDP2 19 5,688 0.472 0 0 0 0
CAR7 19 9,393 0.509 0 0 0 0
MT3 19 1,849 0.534 0 0 0 0
Binary discriminants designate: Long, gene length longer [1] or shorter [0] than 51 kb; AT-rich, GC content lower [1] or higher [0] than 0.44; LA gene, LA gene [1] or non-
LA gene [0]; 59-LAIR, LAIR is present [1] or absent [0] upstream.
doi:10.1371/journal.pone.0004103.t001
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genes contain many neuronal genes (Table S5), their monoallelic
expression would predict a cellular mosaicism and may explain a
phenotypic polymorphism of psychotic conditions or even
personality variations in normal individuals. Apparent similarity
between LAIR and gene deserts [27] or lamina-associated
domains (LADs) [28] is also worth noting.
The c2 toposite identified in this study is unique in that it
involves two segments of DNA from distant genomic locations
(Figure 6A). According to the model, it is possible that the TSS
region of LA gene is in contact with internal sites of the adjacent
LAIR (Figure 6B). This type of interaction may repress the
transcription of LA genes by condensing the chromatin structure
of promoter region. This is consistent with the fact that promoters
for 9 out of 10 LAIR-proximal A1 genes in the tiled region are on
the LAIR side (Table 1). The same situation is noted in the
promoters of LAD-associated genes that are positioned adjacent to
LADs [28]. A long-distance physical contact between inactive
genes and the gene–poor or inactive genomic regions has also been
demonstrated for the inactive b-globin gene in mouse embryonic
brain, but not the one actively transcribed in the liver, by a
chromosome conformation capture technique (4C) [29]. We
propose that LA genes are a distinct category of genes and topo
IIb plays a novel regulatory role by liberating them from the
transcriptional repression exerted by juxtaposed LAIR. While the
activation mechanism of lamina-associated genes is totally
unknown, topo IIb would be the first candidate for such factors
that are actively involved in the gene activation process. In the
present study we focused on c2 sites and LA genes but roles of c1
sites in the control of non-LA genes are less clear at present and
should be addressed in future studies.
Materials and Methods
Animal handling
All experiments were carried out under the control of the
Animal Research Control Committee in accordance with the
Regulation for Animal Experiments of Okayama University
Medical School. All efforts were made to minimize the number
of animals used and their suffering.
Primary culture
Cerebellar tissue was isolated from the Wistar rat 8 days after
birth. Minced tissue was treated briefly with trypsin-EDTA and
DNase I in PBS. Dispersed cells were plated at 2.5610
7 cells per
100 mm plastic dish pre-coated with poly-L-lysine. The cells were
incubated at 37uC in DMEM containing 10% FCS, 25 mM KCl,
and 60 mg/ml kanamycin sulfate. After 15–16 h, medium was
replaced with fresh medium supplemented with 10 mM cytosine
arabinoside to suppress the glial growth. The medium change was
repeated at 24 h and at every 48 h afterwards. When it is required,
expression of topo IIb was inhibited specifically throughout the
culture period by daily addition of 10 mM ICRF-193.
Immunoblotting
Cells grown on culture dishes were lysed directly in SDS-PAGE
sample buffer (50 mM Tris-HCl: pH 6.8, 2 mM EDTA, 2% SDS,
1% 2-mercaptoethanol, 8% glycerol, 0.025% bromophenol blue)
Figure 6. A model that explains the topographical relationship of in vivo toposites and target genes. (A) Possible link between the
reaction mechanism of type II DNA topoisomerases and the generation of two classes of toposites. MAR stands for matrix attachment region. Nuclear
matrix proteins interacting with MAR are designated by ‘‘anchor protein’’. (B) Activation of LA genes by topo IIb. Red arrow and asterisks designate
LA gene and c2 toposites, respectively.
doi:10.1371/journal.pone.0004103.g006
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concentration of nucleic acids in sample was determined by a
fluorometric procedure with Quant-iT RiboGreen RNA Assay Kit
(Molecular Probes, Invitrogen). GENios multi-detection micro-
plate reader (Tecan) was used for detection. Samples equivalent to
0.5–2.0 mg of nucleic acids were subjected to SDS-PAGE and then
transferred to a PVDF membrane by electroblotting. The
membrane was incubated with blocking buffer (5% skim milk,
0.1% Tween 20, 20 mM Tris-HCl: pH 7.6, 150 mM NaCl) for at
least 2 h at room temperature. Immunodetection with first
antibodies and horseradish peroxidase-conjugated second anti-
bodies (listed in Table S4) was performed according to standard
procedure. The peroxidase activity was detected by a chemilumi-
nescence method using an ECL kit (GE Healthcare) and recorded
on VersaDoc MP 5000 Imaging Systems (Bio-Rad).
siRNA experiment
To knockdown topo IIb in cultured granule cells, transfection of
rat topo IIb siRNA was carried out using an electroporation
equipment, Nucleofector, and Rat Neuron Nucleofector Kit
(Amaxa). The cDNA sequence of rat topo IIb (GenBank Accession
AB262979) was used to design siRNAs as siGenome SMARTpool
siRNA (Dharmacon, GE Healthcare). The control siRNA was
Negative Control siRNA (Qiagen). Freshly isolated cerebellar cells
were resuspended in 100 ml of Nucleofector solution and mixed
with 3 mg of siRNA (7.2610
6 cells per reaction). The cell
suspension was transferred to the Nucleofector cuvette and the
transfection sequence was started using program G-13. Immedi-
ately after transfection, 0.5 ml of pre-warmed culture medium was
added to the cuvette. Cells were then transferred to a 6-well plate
containing 1.5 ml of culture medium and incubated in a
humidified incubator (37uC, 5% CO2). Three hours later, the
medium was replaced with fresh medium. During the time before
the RNAi effect becomes significant, topo IIb was suppressed by
10 mM ICRF-193 between 16 h and 2.5 days, and then the
medium was replaced with fresh medium without inhibitor. Our
previous study suggested that the effect of ICRF-193 is fully
reversible and after removing the inhibitor the normal gene
induction sequence proceeds with delays [3]. Total RNA was
isolated at the 5th day to assess the expression of selected genes by
RT-qPCR.
Reverse transcription-quantitative PCR (RT-qPCR)
Total RNA was isolated from the granule cells using the RNeasy
Mini Kit (Qiagen) according to supplier’s instructions. Three
micrograms of total RNA was reverse-transcribed in 60-ml
reactions as recommended by manufacturer, using 5 mM random
hexamer primer, 0.5 mM deoxyribonucleoside triphosphates
(dNTPs), 1 unit/ml RNase inhibitors (Takara Bio) and 10 units/
ml M-MLV reverse transcriptase, RNase H minus (Takara Bio).
Real time qPCR was performed on the GeneAmp 5700 Sequence
Detection System (Applied Biosystems) using SYBR Green I
chemistry in triplicate reactions. Primer sets for qPCR were based
on the rat gene sequences retrieved from the UCSC genome
browser site (listed in Table S3). The amplification was carried out
in a reaction mixture (30 ml) containing 16 SYBR Green PCR
Master Mix (Applied Biosystems), 0.5 mM primers and cDNA
equivalent to 15 ng of RNA. Thermal conditions (for all targets)
were 50uC for 2 min, 95uC for 9 min, followed by 40 cycles of
95uC for 20 sec and 60uC for 1 min. Specific amplification of
correct targets was confirmed by dissociation curve analysis. To
calibrate the reaction, the cDNA template was serially diluted and
amplified each time along with every gene targets.
Construction of exRefSeq
Using the rat genome database (rn3, Jun. 2003), refSeq
(refSeqAli, refGene, refFlat) and xenoRefSeq (xenoRefSeqAli,
xenoRefGene, xenoRefFlat) coordinates were downloaded from
UCSC genome bioinformatics (http://hgdownload.cse.ucsc.edu).
The annotation date for these files was 29-Jul-2007. Available
programs (MySQL, R, and Microsoft Excel) were used to process
the data. All the data sets for refSeq and xenoRefSeq were first
deposited in a MySQL database and then rat, mouse, and human
data were extracted. Items with uncertain genomic position
(designated Un or random) were excluded. Non-rat olfactory and
vomeronasal receptor genes were also eliminated. Furthermore,
the following items were filtered out: RefSeq of low transcript-
genome matching (,60%), mouse RefSeq of low homology
(,85%), and human RefSeq of low homology (,80%). All the
gene names in the remaining items were converted to the mouse
format using the programs g:Convert and g:Orth at the g:Profiler
website (http://biit.cs.ut.ee/gprofiler/) [30]. Overlapping tran-
scription units with the same gene name, genomic position, and
the direction of transcription were unified into a longest
hypothetical transcript and the resulting compilation of 17,799
rat genes was named ‘‘exRefSeq’’ that designates ‘‘extended
RefSeq’’. The genic region was defined as a longest stretch of
overlapping transcripts (including reverse directions) in exRefSeq.
The procedure is illustrated schematically in Figure S3.
Expression array
Expression microarray experiments were performed mostly at
Bio Matrix Research, Inc. (Tokyo, Japan). The labeling procedure
was carried out as described by the manufacturer (Affymetrix,
http://www.affymetrix.com). One microgram of total RNAs from
culture day 1 (D1), day 5 (D5), and day 5 with inhibitor (D5+) were
reverse-transcribed to cDNAs by GeneChip One-Cycle cDNA
Synthesis Kit. The cDNAs were transcribed to cRNAs in vitro with
biotinylated nucleotides using GeneChip IVT Labeling Kit. The
Test3 array was used for quality control. Biotinylated cRNAs were
hybridized to GeneChip Rat Genome 230 2.0 for 16 h at 45uCi n
GeneChip Hybridization oven 640. After hybridization, arrays
were washed and stained with Streptavidin-Phycoerythrin in
GeneChip Fluidics Station 450, and scanned on GeneChip
Scanner 3000. GeneChip Operating Software (GCOS; Affyme-
trix) was used for image processing and data acquisition. The
expression array data were deposited in GEO (GSE13112).
GCOS was also used to normalize the signal levels between
different arrays by applying 50th percentiles and to calculate signal
intensities or reliabilities of each probe. Probes with absent call on
both D1 and D5 arrays or absent on both D5 and D5+ arrays were
relegated to unexpressed genes (group D) and excluded from
further classification. Expressed probes were classified into 9
groups (designated A1, A2, A3, B1, B2, B3, C1, C2, C3) by
applying 2-fold and 0.5-fold thresholds to the combination of two
parameters, induction (D5/D1) and inhibition (D5+/D5) (illus-
trated in Figure 1B). Both unexpressed and expressed probes were
converted to corresponding exRefSeq by g:Profiler. The exRefSeq
genes without assigned probes were grouped as ‘‘N’’ (5,090 genes).
The following rules were applied for grouping the exRefSeq genes
with multiple probes that represent conflicting group assignments.
If an A1 group probe is present in the gene in question, it is
grouped as ‘‘A1’’ regardless of other probes. If A1 probe is absent
but A2 probe is present, that gene is grouped as ‘‘A2’’. Genes
without A1 and A2 probes but having other combination of
different probes are grouped as ‘‘Mix’’. Group D probes in a gene
with an unambiguously assignable probe are neglected. In some
cases minor groups (A3, B1, B3, C1, C2, C3, Mix) are combined
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summarized in Figure S5A.
GO analysis
To analyze the gene ontology (GO) annotation of selected rat
genes, gene names of exRefSeq were converted to corresponding
human gene names using the programs g:Convert and g:Orth at the
g:Profiler site. GO statistics were examined by the program GOstat2
to identify the GO terms that are enriched or depleted between two
sets of genes (http://gostat.wehi.edu.au/cgi-bin/goStat2.pl) [31]. In
the present study, a set of individual gene group was compared to its
complementary set. The length of GO path parameter was set to 1.
Statistical significance for over- or under-represented GO terms in a
group of genes was corrected by the method of Benjamini and
Hochberg. As a featured group of genes, neuronal genes were
selected by using the NCBI Gene database (http://www.ncbi.nlm.
nih.gov/sites/entrez?db=Gene) with search terms: neuron* OR
neural* OR neurite OR axon AND human[ORGN]. Out of 2,844
human neuronal genes, 1,429 genes that possess rat exRefSeq
counterparts were used for GO analysis.
eTIP procedure
Primary cultures of rat cerebellar granule cells at day 2 were
treated with 0.5 mM etoposide (VP-16) in serum-free medium for
15 min. The treated cells on 100 mm dishes were lysed with
750 ml of a buffer containing 1% Sarkosyl, 10 mM Tris-HCl
(pH 7.5), 10 mM EDTA, and protease inhibitor mixture (Com-
plete Mini, Roche) by passing through a 23G needle 10 times.
Concentrated CsCl (7 M) was added to a final concentration of
0.5 M. To fragment DNA, the lysates were sonicated with VP-5S
sonicater (Taitec) for 30 sec at power setting 3. Under these
conditions, length of DNA fragments, as determined by agarose
gel electrophoresis, varied from 0.5 kb to 5 kb. Before immuno-
precipitation (IP), 3 volumes of a buffer containing 10 mM Tris-
HCl (pH 7.5), 10 mM EDTA, 100 mM NaCl, 0.1% Triton X-
100, and protease inhibitor mixture was added to 1 volume of
lysates and the diluted lysates were centrifuged for 15 min at
15,000 rpm at 4uC. The supernatant was pre-cleared with 10 mlo f
Dynabeads Protein G (DYNAL, Invitrogen) by rotating the tubes
for 2 h at 4uC. Unbound fraction recovered by magnetic
separation was used as an input for IP reactions. The reaction
was initiated by the addition of 10 ml of Dynabeads protein G,
which had been pre-incubated with 5 mg of specific antibody (3B6)
or control antibody (mouse IgG). The beads suspension was
incubated overnight at 4uC and the IP fraction was recovered by
magnetic separation followed by washing 3 times with TEST-150
(10 mM Tris-HCl: pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.1%
Triton X-100, protease inhibitor). The IP-beads were then eluted
3 times with 500 ml of TEST-500 (10 mM Tris-HCl: pH 7.5,
10 mM EDTA, 500 mM NaCl, 0.1% Triton X-100, protease
inhibitor) by magnetic separation each time and the eluates were
pooled (designated as P2 fraction). DNA fragments still bound on
the beads (designated as P1 fraction) were treated with 50 mg/ml
RNase A at 55uC for 30 min, 200 mg/ml Proteinase K at 55uC
overnight, and purified by phenol/chloroform extractions followed
by ethanol-precipitation with 10 mg of glycogen. The DNA in IP
input and P2 fraction was also purified and DNA amounts in each
fraction were determined by Quant-iT PicoGreen dsDNA
Quantitation Kit (Molecular Probes, Invitrogen) according to the
manufacture’s protocol.
eTIP control experiments
Nuclei were prepared from 2-week-old rat brain (without
cerebellum) by the high-density sucrose method. By removing the
cerebellar tissue, it was possible to eliminate topo IIa from the
preparation [3]. Nuclear pellet was extracted at 5-mg nucleic
acids/ml with the extraction buffer (20 mM Tris-HCl: pH 7.5,
300 mM NaCl, 140 mM 2-mercaptoethanol, 50 mg/ml BSA) on
ice for 30 min. In the final volume of 20 ml, plasmid pUC18
(0.5 mg) was incubated with nuclear extract (2 ml) at 37uC in the
topo II reaction buffer (50 mM Tris-HCl: pH 8.0, 120 mM KCl,
10 mM MgCl2, 0.5 mM DTT, 0.5 mM EDTA, 0.5 mM ATP,
30 mg/ml BSA). In some reactions, 0.5 mM etoposide was added.
After 15 min, the reaction was terminated either by Sarkosyl-CsCl
(1% Sarkosyl, 0.5 M CsCl, 10 mM EDTA, 10 mM Tris-HCl:
pH 7.5, 16 Complete mini) or SDS (1% SDS, 10 mM EDTA,
50 mM Tris-HCl: pH 8.0, 16 Complete mini). Samples were
digested with SDS/Proteinase K and subjected to electrophoresis
in 1% agarose gel in the presence of 0.5 mg/ml ethidium bromide.
For immunoprecipitation, supercoiled pUC18 DNA (7.5 mg)
was incubated with the nuclear extract at 37uC in the presence of
0.5 mM etoposide (300 ml reaction volume). After 15 min, equal
volume of 26 stop solution (20 mM Tris-HCl, pH 7.5, 2%
Sarkosyl, 20 mM EDTA, 26 Complete mini) was added and
incubated on ice for 15 min, then 7 M CsCl was added to a final
concentration of 0.5 M. Before immunoprecipitation, 3 volumes of
dilution buffer (10 mM Tris-HCl, pH 7.5, 10 mM EDTA,
100 mM NaCl, 16Complete mini) were added. Immunoprecip-
itation procedures were the same as in eTIP. Purified DNA
fractions (IP input, IP, P1 and P2) were analyzed by agarose gel
electrophoresis as described above.
Cultured granule neurons were treated with etoposide and eTIP
fractions (IP input, IP, P1, and P2) were prepared as described in
the eTIP procedure. Protein samples were subjected to Western
blotting to examine the presence of topo IIb. Before electropho-
resis, DNAs cross-linked to topo IIb were digested with RNase-free
DNase I in a buffer supplemented with 10 mM MgCl2. After
incubation at 30uC for 45 min, 0.5 M EDTA was added to a final
concentration of 15 mM to stop the reaction. Proteins in these
fractions were recovered by acetone precipitation with 2 mgo f
BSA as a carrier and subjected to 6.5% SDS-PAGE and
immunoblotting with topo IIb-specific antibody (3B6).
Tiling array
Purified DNA fractions (IP input, P1 and P2) were digested with
MboI and amplified by ligation-mediated PCR (LM-PCR) per-
formed as described [32] with minor modifications in that TaKaRa
LA Taq (Takara Bio) was used for PCR amplification of 26 cycles.
Designing of oligonucleotide probes and preparation of arrays were
performed by NimbleGen. We selected 7 chromosomal regions for
the analysis: chr2:91,018,106 -98,323,667; chr2:217,827,330-
227,366,232; chr4:42,866,895-57,916,607; chr4:135,995,247-
150,677,540; chr5:119,800,001-126,350,000; chr10:20,098,221-
34,042,054; chr19:1-12,000,000. Rat DNA sequences (version
3.1, produced by the Atlas group at Baylor Human Genome
Sequencing Center (HGSC) as part of the Rat Genome Sequencing
Consortium) were retrieved using the UCSC Genome Browser
(http://genome.ucsc.edu). The arrays were tiled with isothermal 50
to 75-mer oligos that were placed at 1 probe/100 bp on repeat-
masked genomic sequence. Hybridization and scanning of the
fluorescence intensities were performed at NimbleGen (http://
www.nimblegen.com/). Briefly, amplified DNA preparations were
labeled with Cy5 (P1 and P2) or Cy3 (IP input) and were hybridized
competitively to the array with Cot-1 DNA. Scanned data were
processed by the supplier’s standard protocol for ChIP-chip analysis
to obtain the scaled log2 (Cy5/Cy3 ratio).
The log2 (P1/input) and log2 (P2/input) values were used for the
computational analysis named ACME (Algorithm for Capturing
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for topo IIb action sites. The window size was set to 1,000 bp and
the threshold to 90%. We calculated the probability values based
on hypergeometric distribution instead of chi-square distribution,
which is used in the original ACME. The array probes associated
with probability values smaller than 10
24.5 were adopted as
toposites. To classify the toposites, significant P1 signals were
subjected to cluster analysis (Ward’s method) between two factors,
log2 (P2/input) and local GC content around toposites. Toposites
were clearly separated into two clusters of comparable size: low P2
signal-high GC content (class 1) and high P2 signal-low GC
content (class 2). The tiling array data were deposited in GEO
(GSE13145).
We scanned the distribution of class 1 (c1) and class 2 (c2)
toposites along the genome by using a sliding-window algorithm.
With respect to the probes that were recognized as a toposite by
ACME, the likelihood of being toposite was split and distributed
evenly to every nucleotide across the probe. Namely, the inverse of
probe length in number of nucleotides was defined as a ‘‘positional
toposite potential’’ assigned to every nucleotide position within the
toposite probe. To assess the toposite density around the
transcription start sites (TSS) and termination sites (TTS) of 318
transcription units located in the tiled region, toposite potentials
within 610 kb from these sites were counted. The potential scores
were then added up in every gene groups of interest that were
aligned at TSS or TTS. Resulting figures were divided by the
number of genes constituting the group in order to enable the
comparison between different gene groups. Entire region of the
20 kb-potential map was scanned with a moving window of 1-bp
step and 1,000-bp width. Sum of the potential scores within the
window was plotted at the centre position as a toposite density.
The highest density score would be 10 by definition. For a control,
the same numbers of toposites were picked up randomly as Monte
Carlo simulation of 10-times repetition and the toposite density
was calculated as stated above.
Shotgun cloning and sequencing
The eTIP DNA fractions (P1 and P2) amplified by LM-PCR
were blunt-ended with T4 DNA polymerase (New England
Biolabs), ligated into the EcoRV site of a zero-background cloning
vector pZErO-2.1 (Invitrogen) and transformed into Escherichia coli
TOP10F’ competent cells (Invitrogen). The transformants were
screened by colony PCR using AmpliTaq Gold DNA polymerase
(Applied Biosystems) with M13RV and M13(-21) vector primers.
The nucleotide sequences of eTIP clones were determined by
direct sequencing of the amplified fragments on the DNA
sequencer 310 according to standard methods (Applied Biosys-
tems). Genomic positions of resulting sequences were determined
on the rat genome (rn3) by BLAT search performed at the UCSC
genome browser website (http://genome.ucsc.edu). The complete
list of eTIP clones is given in Table S1.
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